Am J Epidemiol. 2020 Sep 1;189(9):931-941. doi: 10.1093/aje/kwz283.
Previous findings concerning gastric atrophy as a potential risk factor for esophageal squamous cell carcinoma (ESCC) have been inconsistent. We aimed to test whether gastric atrophy and, further, its interaction with poor oral health elevated the risk of ESCC in a high-risk region of China. Our population-based case-control study in Taixing, China (2010-2014), recruited cases from local hospitals and the local cancer registry. Controls were selected randomly from the local population registry. Ultimately, 1,210 cases and 1,978 controls answered questionnaires and provided blood samples for assay of pepsinogens. Unconditional logistic regression models were used to estimate odds ratios and 95% confidence intervals. Gastric atrophy (defined as a serum level of pepsinogen I of <55 μg/L) was associated with an increased risk for ESCC (odds ratio = 1.61; 95% confidence interval: 1.33, 1.96), even after full adjustment for potential confounding factors. In addition, suggestion of an additive interaction between gastric atrophy and poor oral health was observed (relative excess risk due to interaction = 1.28, 95% confidence interval: 0.39, 2.18). We conclude that gastric atrophy appears to be a risk factor for ESCC in a high-risk region of China, and there is a suggested additive interaction with poor oral health that increases this risk even further.
先前关于胃萎缩作为食管鳞状细胞癌(ESCC)潜在风险因素的研究结果并不一致。我们旨在检验胃萎缩,以及其与口腔健康不良的相互作用是否会在中国高危地区增加 ESCC 的风险。我们在中国泰兴市进行的基于人群的病例对照研究(2010-2014 年),从当地医院和当地癌症登记处招募病例。对照组是从当地人口登记处随机选择的。最终,1210 例病例和 1978 例对照回答了问卷,并提供了血液样本用于胃蛋白酶原检测。采用非条件逻辑回归模型来估计比值比和 95%置信区间。胃萎缩(定义为血清胃蛋白酶原 I 水平<55μg/L)与 ESCC 的风险增加相关(比值比=1.61;95%置信区间:1.33,1.96),即使在充分调整了潜在混杂因素后也是如此。此外,观察到胃萎缩和口腔健康不良之间存在相加交互作用的迹象(交互作用的相对超额风险=1.28;95%置信区间:0.39,2.18)。我们的结论是,胃萎缩似乎是中国高危地区 ESCC 的一个风险因素,并且与口腔健康不良存在相加交互作用,进一步增加了这种风险。